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It has been suggested that anti-HLA antibodies might 
be involved in the pathogenesis of herpes gestationis 
(HG). Accordingly , we have studied the frequency and 
specificity of such antibodies in 26 female patients with 
immunologically proven HG. In addition, to further in-
vestigate the potential association of the husband's an-
tigens in the development of this disorder, we have 
performed HLA typing in 20 of the husbands of these 
women. 
HLA-DR2 was found in 50% of the husbands (controls 
25%, p = 0.04). The increase was more pronounced in 
the husbands of patients with the HLA-DR3, DR4 com-
bination (64%, p < .01) than in the husbands of those 
with other antigen combinations. 
Anti-HLA antibodies were found in 85% of women 
with a history of HG. Approximately 25% of normal, 
multiparous women have such antibodies in their sera. 
In normal women, their presence has not been associated 
with increased fetal or maternal risk. 
These data suggest that the husband's HLA type may 
be associated with the development of HG in the wife. 
Anti-HLA antibodies are present in most patients, but 
their significance remains uncertain. 
Herpes gestationis (HG) is a rare, autoimmune, cutaneous 
disease which tends to first appear during the latter part of 
pregnancy or the puerperium. The disease appears to be me-
diated by a complement (C) fixing immunoglobulin G (IgG) 
antibody specific for a component of the epidermal basement 
membrane zone (BMZ) [1,2] . The antibody is found in low 
t iters in the serum, and titers do not correlate with disease 
severity. In fact, the antibody concentration is often so low 
that lgG is not demonstrable by either direct or indirect im-
munofluorescence (IF). Rather, only the capacity of serum IgG 
to initiate C deposition along t he BMZ of normal skin is seen. 
The unique feature of the HG antibody is its ability to initiate 
extensive deposition of C, and its dependency upon pregnancy 
to manifest this effect. 
The disorder has been reported in association with hydati-
diform moles [3] and pregnancy-derived choriocarcinoma [4] . 
Thus, the presence of placental tissue alone is adequate for the 
development of disease. However, the precise role that the 
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placenta plays in the development of HG is unclear. It is known 
that the direct IF of placentas taken from mothers with HG is 
identical to the IF of "normal" placentas [2] and that placental 
basement membrane (from mothers with HG) does not react 
with the HG antibody [5]. It would thus appear that the 
placenta exerts its effect in some way other than by providing 
a cross-reacting basement membrane with that of skin. 
Paternal histocompatibility (HLA) antigens are expressed in 
the placenta and approximately 25 % of normal, multiparous 
women make antibodies directed against them [6]. The pres-
ence of such antibodies has not been associated with adverse 
pregnancy outcome (6]. Reunala eta! [7] were the first to report 
the occurrence of anti-HLA antibodies in a patient with HG . 
Although their patient had a high titer of anti HLA-B8, a 
paternal histocompatibility antigen present in the child, exten-
sive absorptions of the mother's serum with HLA-B8 positive 
lymphocytes fai led to alter cutaneous basement membrane 
staining by maternal IgG or C. Thus, anti-HLA antibodies do 
not appear to play a direct role in C fixation along the BMZ. 
What other role anti -HLA antibodies might play in this disease 
has not been investigated. Neither the frequency of such anti-
bodies in patients with HG nor their specificity toward any 
subgroup of HLA antigens is known. 
. We recently reported that patients with HG have a greatly 
mcreased frequency of the combined presence of HLA-DR3 
and DR4 (43 % compared to 3% of controls, P c < 0.00001) (8]. 
To further investigate the pathogenesis of this disease we have 
investigated the potential association of HG with 'paternal 
histocompatibility antigens by doing HLA typing on 20 of the 
husbands of t he women in our previous study. In addition, we 
have performed anti-HLA antibody assays on sera from 26 
patients with a history of immunologically proven HG. 
METHODS 
Patient Identification 
. Patients wit h a past history of HG were identified by surveying 
Immunofluorescence laborato ries, t he heads of various dermatology 
t ra ining centers, t he practicing dermatologists in the Dallas- Fort 
Worth a rea, and t he authors of previous papers on HG. Patients were 
accepted as having had HG if t hey had (1) a clinically compatible 
eruption during pregnancy or the puerperium, and (2) positive direct 
IF. One patient had her disease before IF became available, but was 
accepted because she had typical clinical features during multiple 
pregnancies, supporting histopathology and the HLA-DR3, DR4 com-
binat ion characteristic of patients with HG. All of these women had 
one or more pregnancies by a single husband, i.e., husbands of women 
who had been married more t han once were not studied. Children were 
not studied because of their age. Paternity was established by patient 
history. There was no history of previous transfusions in any of these 
women. 
HLA Typing 
HLA-A, 8, and C typing was performed by a standard microcytotox -
icity assay [9] . DR typing was done on purified B cells separated by 
nylon wool adherence [10] . Typing sera were obtained from local 
volun teers and by exchange with other investigators. Subjects were 
tested for 17 HLA-A antigens, 27 HLA-8 antigens, 8 HLA-C antigens, 
and 10 HLA-DR antigens. Normal control individuals were Caucasian 
residents of the Dallas- Fort Worth a rea, typed in our laboratory using 
the same reagents. 
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Anti-HLA Antibodies 
Fresh peripheral blood mononuclear cells (PBM) were obta ined by 
a standard Ficoii-Hypaque notation procedure [11]. Monocytes were 
purified by overnight adherence of PBM to plastic culture dishes [12] . 
Nonadherent lymphocytes were suspended in 0.5 ml of RPM! 1640 
supplemented wit h 5% normal (male) human serum and introduced 
in to a nylon wool column [10] . After 45 min of incubation, T cells were 
eluted using 15 ml of warm RPMI supplemented with 5% normal 
(male) human serum. B cells were obta ined by further elution while 
squeezing t he column. The cells thus obtained were over 80% pure, as 
determined by cytotoxicity using a broadly reactive anti-DR serum. 
Sera to be tested against enriched populations of monocytes or B 
cells were first absorbed with packed, washed platelets pooled from 
over 400 donors. Brie!ly, 0.3 ml of serum was incubated at room 
temperature for 1 h wi t h an equal volume of packed, pooled platelets. 
After incubation, samples were centrifuged at 10,000 g for 15 min in a 
refrigerated centrifuge. 
Sera were tested for ant i-HLA activity by a standard cytotoxicity 
technique [9]. Aliquots of PBM, B cells, and T cells were adjusted to a 
concentration of 3 X 106 cells per mi. Monocytes were concentrated at 
2.5 x 106 cells per mi. T est sera were incubated with PBM for 30 min, 
then with rabbit C for an additional 60 min. Test sera previously 
absorbed with platelets were incubated with B cells or monocytes for 1 
h followed by 2 h with rabbit C. The cells used in these tests were 
obta ined from normal donors of the HLA laboratory reference panel. 
The analys is to determine the specificity of anti-HLA antibodies was 
performed using the SERA TYPING computer program which calcu-
lates chi square and correlation coefficients by comparing test reactions 
with the known distribution of antigens on the target cell s [ 13]. 
RESULTS 
HLA typing of husbands (Table I): In the 20 husbands typed, 
there was a 2-fold increase in HLA-DR2 (50%, controls, 25%, 
p = 0.04) . The increase was more significant when the husbands 
were divided according to the HLA type of their wives. Among 
TABLE I. HLA types of patients and husbands, and anti-HLA 
antibodies in patients with HG 
HLA types Anti-HLA antibodies 
Paitent Patient Husband M,B, cells Anti-HLA 
DR DR PBM" (DR en- specificity riched) 
1 3,4 7,-
2 3,4 2,5 + + 
3 3,4 2,3 + + B7, B27, Bw42, 
DR2 
4 3,4 2,3 + + B7, DR2 
5 3,4 3,4 + A2 
6 3,4 2,- + DR1 
7 3,4 2,7 + Aw23, B12 
8 3,4 2,- + 
9 3,4 1,7 + 
10 3,4 1,4 + + B12 
11 3,w6 w6,w9 + + 
12 3,w6 1,5 + + 
13 4,- 1,- + 
14 4,- 1,w6 
15 4,- 2,7 + + A3, B7, Bw42 
16 2,w6 2,7 + Cw4 
17 w6,- 2,7 + + A2, DR2 
18 w6,- 2,w6 + DR2 
19 7,- 3,- + B7, B8, Bw42, Cw7 
20 w6,9 5,w6 + DRw8 
21 2,3 NT' 
22 3,w6 NT + + B14, Cw8 
23 1,7 NT 
24 1,2 NT + 
25 NT NT + + 
26 3,4 NT + + A1, A9, Bw53, DR2 
a Peripheral blood mononuclear cells. Tests done with unabsorbed 
serum. 
" M,B = purified monocytes and B cells. Tests done after preabsorp-
tion of sera with packed, pooled platelets. 
' NT = not tested. 
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the 10 husbands whose wives had the DR3, DR4 combination, 
6 had DR2. Similarly, of the 5 women with neither DR3 nor 
DR4, 3 had DR2. One additional woman, whose husband was 
not typed, had HLA DR3, DR4, and a high titer of anti -DR2. 
Since her husband was the likely source of antigen, we have 
evidence that 7 of 11 (63%, p < .01) of the husbands of DR3, 
DR4 positive patients have DR2. 
Anti-HLA Antibodies (Table I) 
When patient sera not absorbed with platelets were tested 
against PBM, 58% showed cytotoxicity. When the same sera 
were pretreated by absorption with packed platelets, 69% were 
cytotoxic against purified B cells or monocytes. Eight-five 
percent of sera were positive by one or both of the techniques 
used. 
Specificity could not always be determined. Using cells of 
known HLA type as targets, we could identify anti-HLA spec-
ificity in 14 (58%) of the patients. In 8 other patients the serum 
contained cytotoxic antibodies, but HLA-A, B, C, or DR spec-
ificity could not be determined. Five patients made high titer, 
monospecific antibodies with r values greater than 0.65 (patient 
5, A2; patient 6, DR1; patient 7, B12; patient 17, A2 and DR2; 
patient 20, DRw8) . Nine other patients (patients 3, 4, 10, 15, 
16, 18, 19, 21, 22) had broadly reactive antibodies against cells 
of different HLA types. Of these, 4 patients had anti-B7 (pa-
tients 3, 4, 15, 19) and 4 had anti-DR2 (patients 3, 4, 18, 26) . 
The specificity of the antibodies found in these patients cor-
responded well with the antigens present in their mates. 
The presence of positive findings for anti -HLA antibodies 
did not correlate with the overall number of pregnancies or the 
number of pregnancies associated with HG. The 4 patients with 
3 or more involved pregnancies all had positive results by one 
of the 2 techniques , but 2 of the 5 women with 2 involved 
pregnancies had no measurable anti -HLA activity. 
There was no discernable association between the presence 
of cytotoxic antibodies and clinical disease severity, duration 
of disease, the tendency or severity of recurrence, or the tend-
ency for the children to have transient cutaneous disease at 
birth. 
DISCUSSION 
Reunala et al [7] were the first to suggest that anti-HLA 
antibodies might play some role in the development of HG. 
Because no effect of anti-HLA antibodies could be demon-
strated on the deposition of antibody or C along the cutaneous 
BMZ, the authors felt that the high titer of anti-HLA antibodies 
in their patient might induce abnormal placental function due 
to the formation of immune complexes between placental HLA 
antigens and the maternal antibodies directed against them. 
Anti-HLA antibodies are found in approximately 25% of 
normal multiparous women and their presence has not been 
correlated with adverse pregnancy outcome [6]. Such antibodies 
have also been reported to occur following molar pregnancies, 
indicating that placental tissue alone has adequate represen-
tation of HLA antigens to induce the production of anti-HLA 
antibodies (14] . · 
HG has also been reported in association with hydatidiform 
moles [3,4], indicating that any antigenic stimulus that may be 
required to induce disease is also present within placental 
tissue. Since the placenta has both maternal and paternal 
antigens represented, we investigated the potential association 
of HG with paternal antigens by studying the HLA types of 
the husbands of the women we had previously reported. 
An increase in the frequency of HLA-DR2 in husbands was 
associated with the development of HG in the wife. The in-
crease was highest in the husbands of those with the DR3, DR4 
combination, but was also apparent in the husbands of those 
with neither DR3 nor DR4. We were unable to study the 
husbands of normal women with HLA-DR3, DR4, since this 
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combination is too rare to provide an adequate study group. 
We assume t hat t here is no peculiar antigen distribution in t he 
husbands of these women. We also made no attempt to type 
the children of t hese couples, primarily because of their age. 
Such informat ion would obviously be of great interest. 
Antibodies·against lymphocytes or monocytes occur in most 
women with HG . Most of the women in our study were 1- 5 
years beyond their last pregnancy at the time antibody reactiv-
ity was measured. Since anti-HLA antibodies decrease with 
time, it is likely that an even higher percentage of our patients 
would have had anti -HLA antibodies if studied at the time of 
parturition. 
HLA-A, B, and C antigens are present on essentially all 
nucleated cells, including skin cells (keratinocytes). Only about 
4% of epidermal cells express HLA-DR antigens (Langerhans 
ce lls) . There is no evidence that any of these antigens are 
represented within the BMZ. Further, extensive absorptions of 
Reunala's case with HLA-B8 positive lymphocytes failed to 
alter BMZ staining by t he patient's serum. Thus, anti -HLA 
antibodies are unlikely to play a direct role in the fixation of C 
at the dermal-epidermal junction in patients with HG. 
It is possible that anti-HLA antibodies exert their effect on 
the development of HG indirectly by influencing some aspect 
of immune regulation. It is also possible that the production of 
anti-HLA antibodies, although more common in patients with 
HG , has no relationship to the pathogenesis of this disease. 
The production of these antibodies may be stimulated by the 
same factors that induce anti-BMZ antibody production. Fur-
t her research into the factors that influence product ion of anti-
BMZ and anti-HLA antibodies in this group of patients may 
provide insight into the fundamenta l abnormality of HG. 
The authors wish to thank Gabriel Nunez, M.D. for his help and 
expertise. 
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Kathon Biocide: Manifestation of Delayed Contact Dermatitis in Guinea 
Pigs Is Dependent on the Concentration for Induction and Challenge 
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The potential of Kathon biocide, an aqueous solution 
containing, as active ingredients (a.i.), a mixture of 5-
chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-
isothiazolin-3-one (14.4% a.i.), to produce delayed con-
tact dermatitis, a sensitization response, was evaluated 
in outbred Hartley guinea pigs by a modified Buehler's 
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Abbrev iations: 
a.i. : active ingredients 
EC50: concentration at wh ich delayed contact dermatitis was seen 
in 50% of the population 
occluded epicutaneous patch technique. The relationship 
of the response as a function of induction/elicitation 
concentrations was investigated. Groups of guinea pigs 
received 9 induction doses of the biocide, 3 times a week, 
at concentrations ranging from 25- 2000 ppm a.i. These 
guinea pigs were challenged with the biocide at concen-
trations ranging from 20-2000 ppm a .i. , and the appli-
cation sites were scored for erythema 24 and 48 h after 
the challenge. The incidence of delayed contact derma-
titis in induced guinea pigs was dependent on both the 
induction and challenge concentrations. The EC5 0 (con-
centration at which delayed contact dermatitis was seen 
in 50% of the population) for induction at a challenge 
concentration of 2000 ppm a.i., a nonirritating concen-
tration, was estimated to be 88 ppm a.i. with a slope of 
